Pfizer compares two pill forms of new drug in small Healthy-Volunteer study
NCT ID NCT06670170
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage study tested two different pill versions of an experimental drug called PF-07976016 in 12 healthy adults. The main goal was to measure how much of the drug gets into the blood and how the body processes it. This type of study helps researchers choose the best formulation for future trials, but does not test whether the drug treats any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PF-07976016
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults